What do we need to know about non-A-to-E viral hepatitis?
Related Experiment Video
Updated: Sep 18, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
1Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA.
Insights
New hepatotrophic viruses like GB virus-C, TT virus, and SEN virus are emerging globally. While their prevalence is documented, definitive links to specific liver diseases remain unproven, though SEN virus shows potential in cryptogenic chronic hepatitis.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- The spectrum of hepatotrophic viruses is expanding with recent discoveries.
- GB virus-C and TT virus have demonstrated global prevalence, particularly in certain populations.
- The etiological role of these novel viruses in liver disease is under investigation.
Purpose of the Study:
- To review the current understanding of newly identified hepatotrophic viruses.
- To discuss the prevalence and potential clinical significance of GB virus-C, TT virus, and SEN virus.
- To highlight the ongoing search for evidence linking these viruses to specific liver pathologies.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of prevalence data in different populations.
- Evaluation of clinical case reports and research on viral associations with liver disease.
Main Results:
- GB virus-C prevalence ranges from 1.2% to 13% globally in healthy donors, with higher rates in intravenous drug users.
- TT virus is globally distributed, but its direct link to specific liver diseases is not definitively established.
- SEN virus is a potential novel agent associated with cryptogenic chronic hepatitis, pending further research.
Conclusions:
- The clinical significance of GB virus-C and TT virus in liver disease requires further investigation.
- SEN virus presents a promising area of research for cryptogenic chronic hepatitis.
- Continued research is essential to elucidate the role of these emerging viruses in human health.
Abstract:
The list of potential hepatotrophic viruses continues to grow, with the recent discovery of the GB virus-C, the TT virus, and the SEN virus. Prevalence rates of the GB virus-C have ranged from 1.2% to 13% among healthy blood donors from all over the world. Higher prevalence rates have been reported among intravenous drug users. Similarly, the TT virus has a global distribution. However, in spite of numerous reports of the presence of both of these viruses in various kinds of liver diseases, definite evidence linking it to a specific disease or illness is lacking. The SEN virus is thought to be a novel viral agent that may be linked to cryptogenic chronic hepatitis, but data are awaited.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Yellow Fever
Hepatitis
Genital Herpes
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction

